Reshape Lifesciences Stock Market Value
| RSLS Stock | USD 5.55 0.03 0.54% |
| Symbol | ReShape |
ReShape Lifesciences Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReShape Lifesciences. If investors know ReShape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReShape Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 76.2 | Revenue Per Share 27.638 | Quarterly Revenue Growth (0.13) | Return On Assets (0.63) | Return On Equity (1.85) |
The market value of ReShape Lifesciences is measured differently than its book value, which is the value of ReShape that is recorded on the company's balance sheet. Investors also form their own opinion of ReShape Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is ReShape Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReShape Lifesciences' market value can be influenced by many factors that don't directly affect ReShape Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReShape Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReShape Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReShape Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ReShape Lifesciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ReShape Lifesciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ReShape Lifesciences.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in ReShape Lifesciences on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding ReShape Lifesciences or generate 0.0% return on investment in ReShape Lifesciences over 30 days. ReShape Lifesciences is related to or competes with SINTX Technologies, Bone Biologics, Tivic Health, Nuwellis, Tenon Medical, Helius Medical, and Heart Test. ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and m... More
ReShape Lifesciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ReShape Lifesciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ReShape Lifesciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 42.57 | |||
| Value At Risk | (10.12) | |||
| Potential Upside | 7.93 |
ReShape Lifesciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ReShape Lifesciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ReShape Lifesciences' standard deviation. In reality, there are many statistical measures that can use ReShape Lifesciences historical prices to predict the future ReShape Lifesciences' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.52) | |||
| Treynor Ratio | (2.31) |
ReShape Lifesciences Backtested Returns
ReShape Lifesciences maintains Sharpe Ratio (i.e., Efficiency) of -0.0988, which implies the firm had a -0.0988% return per unit of standard deviation over the last 3 months. ReShape Lifesciences exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ReShape Lifesciences' Coefficient Of Variation of (1,138), risk adjusted performance of (0.06), and Market Risk Adjusted Performance of (2.30) to confirm the risk estimate we provide. The company holds a Beta of 0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, ReShape Lifesciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding ReShape Lifesciences is expected to be smaller as well. At this point, ReShape Lifesciences has a negative expected return of -0.69%. Please make sure to check ReShape Lifesciences' maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and relative strength index , to decide if ReShape Lifesciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.36 |
Poor reverse predictability
ReShape Lifesciences has poor reverse predictability. Overlapping area represents the amount of predictability between ReShape Lifesciences time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ReShape Lifesciences price movement. The serial correlation of -0.36 indicates that just about 36.0% of current ReShape Lifesciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
ReShape Lifesciences lagged returns against current returns
Autocorrelation, which is ReShape Lifesciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ReShape Lifesciences' stock expected returns. We can calculate the autocorrelation of ReShape Lifesciences returns to help us make a trade decision. For example, suppose you find that ReShape Lifesciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ReShape Lifesciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ReShape Lifesciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ReShape Lifesciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ReShape Lifesciences stock over time.
Current vs Lagged Prices |
| Timeline |
ReShape Lifesciences Lagged Returns
When evaluating ReShape Lifesciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ReShape Lifesciences stock have on its future price. ReShape Lifesciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ReShape Lifesciences autocorrelation shows the relationship between ReShape Lifesciences stock current value and its past values and can show if there is a momentum factor associated with investing in ReShape Lifesciences.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.